Intra-Cellular Therapies Inc. buy Vassago1
Start price
16.12.21
/
50%
€32.60
Target price
16.12.22
-
Performance (%)
38.19%
End price
25.12.21
€45.05
Summary
This prediction ended on 25.12.21 with a price of €45.05. The BUY prediction by Vassago1 for Intra-Cellular Therapies Inc. saw massive gains of 38.19%. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to Vassago1 what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Vassago1 for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy Intra-Cellular Therapies Inc.